We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PCH
1101
DELISTED
PotlatchDeltic
PCH
| $4.27M | 0.01% |
93,514
+4,584
| +5% | +$198K |
|
1102
International Bancshares
IBOC
$4.71B
| $4.27M | 0.01% |
120,648
+4,288
| +4% | +$161K |
|
|
MDRX
1103
DELISTED
Veradigm Inc. Common Stock
MDRX
| $4.26M | 0.01% |
336,347
+14,027
| +4% | +$166K |
|
1104
Plexus
PLXS
$6.59B
| $4.24M | 0.01% |
73,430
+19,644
| +37% | +$1.1M |
|
|
CVG
1105
DELISTED
Convergys
CVG
| $4.24M | 0.01% |
200,391
+1,868
| +0.9% | +$43.9K |
|
1106
Ligand Pharmaceuticals
LGND
$5.78B
| $4.23M | 0.01% |
64,086
+16,815
| +36% | +$1.11M |
|
1107
ATI
ATI
$25.2B
| $4.21M | 0.01% |
234,612
+6,268
| +3% | +$118K |
|
1108
Globus Medical
GMED
$10.7B
| $4.21M | 0.01% |
142,236
+7,616
| +6% | +$208K |
|
|
STOR
1109
DELISTED
STORE Capital Corporation
STOR
| $4.2M | 0.01% |
176,034
+18,855
| +12% | +$457K |
|
1110
Granite Construction
GVA
$5.28B
| $4.2M | 0.01% |
83,593
+2,328
| +3% | +$124K |
|
1111
Popular Inc
BPOP
$11.2B
| $4.19M | 0.01% |
102,969
-3,829
| -4% | -$165K |
|
1112
GameStop
GME
$9.73B
| $4.19M | 0.01% |
743,664
-676
| -0.1% | -$4.13K |
|
1113
Compass Minerals
CMP
$1.22B
| $4.18M | 0.01% |
61,544
+2,238
| +4% | +$171K |
|
1114
Entegris
ENTG
$18.1B
| $4.17M | 0.01% |
178,377
+7,291
| +4% | +$151K |
|
|
ELLI
1115
DELISTED
Ellie Mae Inc
ELLI
| $4.17M | 0.01% |
41,566
+1,881
| +5% | +$173K |
|
1116
Independent Bank
INDB
$3.98B
| $4.14M | 0.01% |
63,745
+22,141
| +53% | +$1.43M |
|
|
TIME
1117
DELISTED
Time Inc.
TIME
| $4.14M | 0.01% |
213,913
+4,164
| +2% | +$78.9K |
|
1118
HNI Corp
HNI
$3.05B
| $4.13M | 0.01% |
89,571
+975
| +1% | +$46.9K |
|
1119
Mercury Insurance
MCY
$5.89B
| $4.13M | 0.01% |
67,640
+2,071
| +3% | +$124K |
|
|
HOUS
1120
DELISTED
Anywhere Real Estate
HOUS
| $4.12M | 0.01% |
138,446
+9,724
| +8% | +$264K |
|
|
FTR
1121
DELISTED
Frontier Communications Corp.
FTR
| $4.11M | 0.01% |
128,075
+1,608
| +1% | +$73.7K |
|
|
AF
1122
DELISTED
Astoria Financial Corporation
AF
| $4.11M | 0.01% |
200,145
+51,444
| +35% | +$994K |
|
|
CPN
1123
DELISTED
Calpine Corporation
CPN
| $4.1M | 0.01% |
371,318
+4,945
| +1% | +$56.8K |
|
|
AAN.A
1124
DELISTED
The Aaron's Company Inc Class A
AAN.A
| $4.1M | 0.01% |
137,923
+2,925
| +2% | +$87K |
|
|
EBIX
1125
DELISTED
Ebix Inc
EBIX
| $4.1M | 0.01% |
66,956
+9,818
| +17% | +$583K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.